Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$994,229
+$189,516 QoQ
Shares Held
3,951
+6.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
#2,545
of 4,153 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Goldstein Advisors, LLC holds $3,737,042 across 6 Drug Manufacturers - General names. ABBV ranks #2 (26.6% of the industry book) .
All Filings in ABBV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $994,229 | 3,951 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $804,713 | 3,700 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $812,967 | 3,558 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $749,494 | 3,237 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $622,198 | 3,352 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,147,331 | 5,476 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $945,364 | 5,320 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,050,593 | 5,320 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $880,583 | 5,134 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $913,049 | 5,014 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $772,370 | 4,984 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $722,344 | 4,846 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $583,650 | 4,332 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $769,119 | 4,826 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $851,684 | 5,270 | Shares | Sole | 2023-02-03 | |
| No filing history on record for this holder in this stock. | ||||||